Faster global financial news!
CVS Health
-
CVS Health Plans to Spin Off Its $117B Healthcare Business Amid Political Pressure
CVS Health is planning to spin off its $117 billion healthcare business and may divest its pharmacy operations amid mounting political pressure. This move comes as pharmacy benefit managers (PBMs) and
-
CVS Health (CVS) shares rose 3.7% on Tuesday after Jefferies reiterated a Buy rating with a $120 price target.
Jefferies analyst Brian Tanquilut reiterated a "Buy" rating on CVS Health with a $120 price target, implying a 28% upside from Monday's closing price. The analyst named CVS as one of his top picks, no
-
CVS Health stock has risen over 18% year-to-date, outperforming the S&P 500, with Wall Street analysts projecting a further 22% upside to a consensus target of $114.59 per share.
The pharmacy chain's strong performance is attributed to two consecutive quarters of estimates-beating earnings in Q1 and Q2 2026, where it topped revenue and profitability consensus. Notably, its non
-
CVS Health shares dip about 6% after company issues early warnings for 2027, citing expected decline in Caremark membership and 340B drug-discount program pressures
Despite handily beating Wall Street’s expectations for the most recent quarter and raising its 2026 earnings guidance, the healthcare giant's stock fell due to its unusually early commentary on 2027.
-
CVS Health Plans to Spin Off Its $117B Healthcare Business Amid Political Pressure
CVS Health is planning to spin off its $117 billion healthcare business and may divest its pharmacy operations amid mounting political pressure. This move comes as pharmacy benefit managers (PBMs) and
-
CVS Health (CVS) shares rose 3.7% on Tuesday after Jefferies reiterated a Buy rating with a $120 price target.
Jefferies analyst Brian Tanquilut reiterated a "Buy" rating on CVS Health with a $120 price target, implying a 28% upside from Monday's closing price. The analyst named CVS as one of his top picks, no
-
CVS Health stock has risen over 18% year-to-date, outperforming the S&P 500, with Wall Street analysts projecting a further 22% upside to a consensus target of $114.59 per share.
The pharmacy chain's strong performance is attributed to two consecutive quarters of estimates-beating earnings in Q1 and Q2 2026, where it topped revenue and profitability consensus. Notably, its non
-
CVS Health shares dip about 6% after company issues early warnings for 2027, citing expected decline in Caremark membership and 340B drug-discount program pressures
Despite handily beating Wall Street’s expectations for the most recent quarter and raising its 2026 earnings guidance, the healthcare giant's stock fell due to its unusually early commentary on 2027.
- No data
CVS Health
24H Trending
-
1
SCIX Token Analysis: The Synthetic Asset Platform Token Based on Binance Smart Chain and Its Market Status
-
2
Lombard (BARD) Token Analysis: Value, Investment Potential, and Risk Assessment
-
3
A Review of Major Global Digital Currency Trading Platforms and Market Landscape
-
4
Mainstream Cryptocurrency Exchange Registration Guide: How to Start Trading Bitcoin
-
5
Antminer S9 Retirement: Bitcoin Hashrate Doesn't Plummet, Continues to Grow
-
6
What is SHFT? Shyft Network Project and Current Trading Activity
-
7
Current State of Bitcoin Regulation in Mainland China: No Legitimate Trading Platforms or Apps Exist
-
8
Bitcoin Leveraged Trading Analysis: Definition, Operations, and Risk Management
-
9
Dogecoin Secure Trading Platforms Analysis: Selection Guide and Mainstream Options
-
10
PHA Coin Trading and Exchange Listing Guide
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
